Lantern Pharma is an AI-driven biotechnology company specializing in precision oncology therapeutics. Their proprietary RADR® platform leverages artificial intelligence, machine learning, and big data analytics to accelerate the discovery, development, and personalization of cancer therapies. Lantern Pharma partners with academic and biopharma entities to identify drug mechanisms, stratify patients, predict drug combinations, and improve clinical trial outcomes, making cancer drug development faster, less costly, and more targeted.
Visit Lantern Pharma's official website for product details and getting started.
Detailed information about the RADR® platform and its capabilities in oncology drug discovery.
Information on the targeted clinical trials proposed by Lantern Pharma based on their AI-driven analysis.
Details on how pharmaceutical companies and research organizations can collaborate with Lantern Pharma.
Insights and updates on cancer research and precision oncology.
Latest news and announcements from Lantern Pharma.
Explore career opportunities at Lantern Pharma and join the team.